Arog
IPO News: Filed S-1: Arog Pharmaceuticals files $75mm IPO
Arog

Arog Pharmaceuticals                                    

NASADQ:  AROG

Initial Filing Date:  09/28/18

Size:  $75mm

Bookrunners:  CITI | RBC | NOM

Major Holders:  Executives & Directors (Executive Chairman, Dr. Vinay Jain and CEO, Scott Salka)

Description:  Arog Pharmaceuticals is a late-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need.

Note: Emerging Growth Company; This offering includes a dual class structure where each share of Class A common stock will entitle its holder to one vote per share and each share of Class B common stock will entitle its holder to ten votes per share

 

Reference Link: S-1